AIM2 and atherosclerosis: However, AIM2 also recognizes dsDNA released by host cells and can contribute to the development of aseptic inflammatory diseases, such as ischemic brain damage, diabetes, atherosclerosis, and chronic nephritis, by stimulating the production and release of inflammatory cytokines [21–24].